Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis-Reference-Cited by-同舟云学术

Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis

Published:1991-10-15 Issue:8 Volume:68 Page:1795-1798
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Fabris Carlo,Basso Daniel A.,Leandro Gioacchino,Meggiato Tamara,Elba Silvana,Piera Panozzo Maria,Del Favero Giuseppe,Fogar Paola,Di Mario Francesco,Naccarato Remo

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference25 articles.

1. Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9.

2. Initial clinical evaluation of an immunoradiometric assay for CA 19-9 using the nci serum bank

3. Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases.

4. Measurement of a monoclonal-antibody-defined antigen (CA 19-9) in the sera of patients with malignant and nonmalignant diseases comparison with carcinoembryonic antigen

5. Prospective Evaluation of the Diagnostic Efficacy of CA 19–9 Assay as a Marker for Gastrointestinal Cancers

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease;Cochrane Database of Systematic Reviews;2021-04-15

2. MicroRNA-33b inhibits liver cancer cell proliferation, migration and invasion via down-regulation of Fli-1 and MMP-2 protein expressions;TROP J PHARM RES;2020

3. Role of Biomarkers and Biopsy in Hepatocellular Carcinoma;Clinics in Liver Disease;2020-11

4. Rethinking Resection and Transplant Candidacy for HCC: Should Tumor Biology Replace Size-Based Criteria?;Annals of Surgical Oncology;2019-11-14

5. Small molecule metabolite biomarkers for hepatocellular carcinoma with bile duct tumor thrombus diagnosis;Scientific Reports;2018-02-19